Crossmark

Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation

Crossref DOI link: https://doi.org/10.1039/D0BM00338G

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Zhao, Zongren

Shen, Jiawei

Zhang, Long

Wang, Lansheng

Xu, Haoyue

Han, Yuhan

Jia, Jun

Lu, Yang

Yu, Rutong

Liu, Hongmei https://orcid.org/0000-0002-0473-0030
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81772665)

Jiangsu Science and Technology Department (BE2016646)

Jiangsu Provincial Commission of Health and Family Planning (Q201608)
License Information

Accepted Manuscript valid from 2021-06-04
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

ASSOCIATED ARTICLES

CrossRef DOI Link to Correction:: https://doi.org/10.1039/D0BM90060E

CrossRef DOI Link to Correction:: https://doi.org/10.1039/D1BM90016A

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Hongmei Liu (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 2 March 2020; Accepted 28 May 2020; Accepted Manuscript published 4 June 2020; Advance Article published 23 June 2020; Version of Record published 30 September 2020